Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study.
Savaş, Emine Merve
Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. [electronic resource] - Metabolic syndrome and related disorders 05 2020 - 197-205 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-8518
10.1089/met.2019.0074 doi
Adult
Apoptosis Regulatory Proteins--blood
Biomarkers--blood
C-Reactive Protein--analysis
Case-Control Studies
Chemokine CCL2--blood
Female
Humans
Male
Metabolic Syndrome--blood
Middle Aged
Pilot Projects
Receptors, Scavenger--blood
Up-Regulation
Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. [electronic resource] - Metabolic syndrome and related disorders 05 2020 - 197-205 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-8518
10.1089/met.2019.0074 doi
Adult
Apoptosis Regulatory Proteins--blood
Biomarkers--blood
C-Reactive Protein--analysis
Case-Control Studies
Chemokine CCL2--blood
Female
Humans
Male
Metabolic Syndrome--blood
Middle Aged
Pilot Projects
Receptors, Scavenger--blood
Up-Regulation